Press Releases

Jump To:

Media Contact:
Lyndsey Scull
Vice President, Communications
lscull@alliancerm.org

The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2018 Cell & Gene Meeting on the Mesa

July 17, 2018

WASHINGTON, D.C.

The Alliance for Regenerative Medicine (ARM), the international advocacy organization for the cell and gene therapy and broader regenerative medicine sector, today released the initial slate of presenting companies at the 2018 Cell & Gene Meeting on the Mesa. The Cell & Gene Meeting on the Mesa Partnering Forum features presentations by 60+ leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering and broader regenerative medicine technologies.


The Alliance for Regenerative Medicine Announces 2019 Cell & Gene Meeting on the Mediterranean

July 13, 2018

WASHINGTON, D.C.

The Alliance for Regenerative Medicine (ARM), the international advocacy organization for the cell and gene therapy and broader regenerative medicine sector, announced it will hold its first annual Cell & Gene Meeting on the Mediterranean on April 23-24, 2019 in Barcelona, Spain. The event, modeled after the organization’s highly successful Cell & Gene Meeting on the Mesa held annually in La Jolla, California, is expected to attract more than 250 attendees, including senior executives from leading cell therapy, gene therapy, and tissue engineering companies worldwide, large pharma and biotech representatives, institutional investors, academic research institutions, patient foundations, disease philanthropies, and members of the life science media community.

 


The Alliance for Regenerative Medicine Announces Third and Final Reimbursement and Market Access-Focused White Paper in Three-Part Series Published in In Vivo

July 12, 2018

WASHINGTON, D.C.

The Alliance for Regenerative Medicine (ARM) today announced the publication of its reimbursement and market-access focused white paper, “Moving From Chronic Therapies To Cures – Creating A Pathway To Enable New Payment Models,” available online today in the journal In Vivo.


The Alliance for Regenerative Medicine Publishes Position on Proposed Regulation on Health Technology Assessment and Amending Directive 2011/24/EU

July 11, 2018

BRUSSELS, Belgium and WASHINGTON, D.C.